KK
HRMY icon

KLP Kapitalforvaltning’s Harmony Biosciences HRMY Stock Holding History

KLP Kapitalforvaltning’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
40,500
+1,600
+4% +$50.5K ﹤0.01% 930
2026
Q1 		$1.09M Hold
38,900
– – ﹤0.01% 984
2025
Q4 		$1.46M Buy
38,900
+13,100
+51% +$431K 0.01% 840
2025
Q3 		$711K Hold
25,800
– – ﹤0.01% 1226
2025
Q2 		$815K Buy
25,800
+2,800
+12% +$90.1K ﹤0.01% 1092
2025
Q1 		$763K Hold
23,000
– – ﹤0.01% 1074
2024
Q4 		$791K Buy
+23,000
New +$790K ﹤0.01% 1098

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's HRMY Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Harmony Biosciences (HRMY) stake by 4.1% in Q2 2026, buying an estimated $50.5K and bringing the position to 40,500 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #930.

KLP Kapitalforvaltning first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • KLP Kapitalforvaltning held 40,500 shares of Harmony Biosciences worth $1.47M as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,600 Harmony Biosciences shares in Q2 2026, an estimated $50.5K.
  • Harmony Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #930 holding.
  • KLP Kapitalforvaltning first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.